hLL1

{
  "id": "MLC-T-ONC-003932",
  "term": "hLL1",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein on the surface of myeloma cells and certain other types of cells. It may help kill cancer cells. hLL1 is a type of monoclonal antibody. Also called IMMU-110 and milatuzumab.",
  "expansions": [
    "milatuzumab"
  ],
  "synonyms": [
    "IMMU-110"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/hll1/"
}